BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Treatment
41 results:

  • 1. SERPINE2 promotes liver cancer metastasis by inhibiting c-cbl-mediated EGFR ubiquitination and degradation.
    Zhang S; Jia X; Dai H; Zhu X; Song W; Bian S; Wu H; Chen S; Tang Y; Chen J; Jin C; Zhou M; Xie H; Zheng S; Song P
    Cancer Commun (Lond); 2024 Mar; 44(3):384-407. PubMed ID: 38407942
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma.
    Zhang YB; Yang G; Bu Y; Lei P; Zhang W; Zhang DY
    World J Gastroenterol; 2023 Nov; 29(43):5804-5817. PubMed ID: 38074914
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An evaluation of 20-year survival of radiofrequency ablation for hepatocellular carcinoma as first-line treatment.
    Bai XM; He ZH; Wu H; Yang W; Wang S; Zhang ZY; Wu W; Yan K; Chen MH; Nahum Goldberg S
    Eur J Radiol; 2023 Nov; 168():111094. PubMed ID: 37738836
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of RETREAT and CCFSS Scoring Systems for Risk Estimation of Hepatocellular Carcinoma Recurrence After Radical Resection.
    Zhang S; Zhang X; Mo C; Luo Y
    Altern Ther Health Med; 2023 Nov; 29(8):694-698. PubMed ID: 37678878
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.
    Lui GC; Hui VW; Sze SF; Wong BC; Cheung C; Lee MP; Yip TC; Tse YK; Lai JC; Chan HL; Wong VW; Hui YT; Wong GL
    Aliment Pharmacol Ther; 2023 Oct; 58(8):814-823. PubMed ID: 37515399
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MRI-based radiomics model and nomogram for predicting the outcome of locoregional treatment in patients with hepatocellular carcinoma.
    Wang Y; Liu Z; Xu H; Yang D; Jiang J; Asayo H; Yang Z
    BMC Med Imaging; 2023 May; 23(1):67. PubMed ID: 37254089
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A multi-scale, multi-region and attention mechanism-based deep learning framework for prediction of grading in hepatocellular carcinoma.
    Wei J; Ji Q; Gao Y; Yang X; Guo D; Gu D; Yuan C; Tian J; Ding D
    Med Phys; 2023 Apr; 50(4):2290-2302. PubMed ID: 36453607
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ZC3H15 promotes glioblastoma progression through regulating EGFR stability.
    Hou J; Xu M; Gu H; Pei D; Liu Y; Huang P; Chang H; Cui H
    Cell Death Dis; 2022 Jan; 13(1):55. PubMed ID: 35027542
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Systemic Mastocytosis: Advances in Diagnosis and Current Management.
    Pullarkat ST; Wu W; Pullarkat V
    Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Recurrent colorectal liver metastasis patients could benefit from repeat hepatic resection.
    Liu W; Liu JM; Wang K; Wang HW; Xing BC
    BMC Surg; 2021 Aug; 21(1):327. PubMed ID: 34399728
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Use of Ulipristal Acetate and Risk of liver Disease: A Nationwide Cohort Study.
    Yoon EL; Yuk JS
    J Clin Endocrinol Metab; 2021 May; 106(6):1773-1782. PubMed ID: 33567071
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
    Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
    Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
    Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
    Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
    Liu W; Xu H; Ying X; Zhang D; Lai L; Wang L; Tu J; Ji J
    Med Sci Monit; 2020 Jul; 26():e923263. PubMed ID: 32667906
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison of intravoxel incoherent motion imaging, diffusion kurtosis imaging, and conventional DWI in predicting the chemotherapeutic response of colorectal liver metastases.
    Zhang H; Li W; Fu C; Grimm R; Chen Z; Zhang W; Qiu L; Wang C; Zhang X; Yue L; Hu X; Guo W; Tong T
    Eur J Radiol; 2020 Sep; 130():109149. PubMed ID: 32659615
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. cbl0137 administration suppresses human hepatocellular carcinoma cells proliferation and induces apoptosis associated with multiple cell death related proteins.
    Albahde MAH; Zhang P; Chen H; Wang W
    Neoplasma; 2020 May; 67(3):547-556. PubMed ID: 32202904
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Value of serum alpha-fetoprotein for the prognostic evaluation of hepatitis B virus-related acute-on-chronic liver failure treated with artificial liver].
    Qin S; Tang SH; Wang XH; Wang XP; Sun MY; Wu XL; Zeng WZ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):69-72. PubMed ID: 32023703
    [No Abstract]    [Full Text] [Related]  

  • 18. The Growing Problem of Hepatitis C Virus Infection: The Case of West Virginia.
    Phillips M; Abboud J; Abodunde B; Paul DP; Coustasse A
    Health Care Manag (Frederick); 2020; 39(1):2-11. PubMed ID: 31876587
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Long-acting octreotide treatment has no impact on tumor uptake of 99mTc-HYNIC-TOC in patients with neuroendocrine tumors.
    Li Y; Xu J; Xu X; Zhang J; Zhang Y
    Nucl Med Commun; 2019 Oct; 40(10):1005-1010. PubMed ID: 31365494
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
    Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.